Breast cancer in women : diagnosis, treatment and follow-up [printed text] / Hans Wildiers, Author ; Sabine Stordeur, Author ; Joan Vlayen  , Author ; Rob Scholten, Author ; Fleur van de Wetering, Author ; Claire Bourgain, Author ; B. Carly, Author ; M.-R. Christiaens, Author ; V. Cocquyt, Author ; E. Lifrange, Author ; J.-C. Schobbens, Author ; Mireille Van Goethem, Author ; Geert Villeirs, Author ; Erik Van Limbergen, Author ; P. Neven, Author . - 3 ed. . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2013 . - 83 p. : Ill. ; A4. - ( KCE Reports. Good Clinical Practice (GCP); 143) . ISSN : D/2013/10.273/38 : € 0,00 Study n° 2012-33 Languages : English ( eng)
| Descriptors: |
Classification
WP 870 - Breast - - Neoplasms
Indexation
2010-33 ; Breast Neoplasms ; Carcinoma, Ductal, Breast ; Neoplasm Metastasis ; Practice Guideline [Publication type] ; R143
|
| Contents note: |
1 INTRODUCTION 8 -- 1.1 THE NEED FOR A GUIDELINE 8 -- 1.2 REMIT OF THE GUIDELINE 9 -- 1.2.1 Overall objectives 9 -- 1.2.2 Target users of the guideline 9 -- 1.3 STATEMENT OF INTENT 9 -- 1.4 FUNDING AND DECLARATION OF INTEREST 9 -- 2 METHODOLOGY 10 -- 2.1 THE GUIDELINE DEVELOPMENT GROUP 10 -- 2.1.1 Introduction 10 -- 2.1.2 The Guideline Development Group 10 -- 2.2 GENERAL APPROACH 10 -- 2.3 CLINICAL QUESTIONS 10 -- 2.4 CLINICAL PRACTICE GUIDELINES 11 -- 2.4.1 Search for evidence 11 -- 2.4.2 Quality appraisal 12 -- 2.5 ADDITIONAL EVIDENCE FROM ORIGINAL STUDIES (2010) 12 -- 2.5.1 Search for evidence 12 -- 2.5.2 Quality appraisal 12 -- 2.6 GUIDELINE UPDATE (2013) 12 -- 2.6.1 Search for evidence 13 -- 2.6.2 Quality appraisal 13 -- 2.7 ANALYSIS (GUIDELINE UPDATE 2013) 14 -- 2.8 DATA EXTRACTION 14 -- 2.9 GRADING OF EVIDENCE 14 -- 2.10 FORMULATION OF RECOMMENDATIONS 19 -- 2.11 CONSULTATION AND PEER REVIEW 22 -- 2.11.1 Healthcare professionals 22 -- 2.11.2 Patient representatives. 22 -- 2.12 FINAL VALIDATION 23 -- 3 CLINICAL RECOMMENDATIONS 24 -- 3.1 GENERAL ALGORITHM 24 -- 3.2 DIAGNOSIS OF BREAST CANCER 25 -- 3.2.1 Triple assessment 25 -- 3.2.2 Magnetic resonance imaging (MRI) 25 -- 3.2.3 99mTc-MIBI scintimammography (SMM) 26 -- 3.2.4 PET Scan 26 -- 3.2.5 Hormonal receptor assessment 27 -- 3.2.6 Tumour markers 27 -- 3.3 STAGING OF BREAST CANCER 28 -- 3.3.1 Routine staging tests 28 -- 3.3.2 Magnetic resonance imaging (MRI) 28 -- 3.3.3 Axillary ultrasonography 29 -- 3.3.4 PET scan 30 -- 3.4 TREATMENT OF NON-INVASIVE BREAST CANCER 31 -- 3.4.1 Early precursor and high-risk lesions 31 -- 3.4.2 Ductal carcinoma in situ 32 -- 3.4.3 Paget’s disease 34 -- 3.5 TREATMENT OF EARLY INVASIVE BREAST CANCER 35 -- 3.5.1 Neoadjuvant treatment 35 -- 3.5.2 Surgery to the breast 35 -- 3.5.3 Surgery to the axilla 36 -- 3.5.4 Adjuvant therapy 42 -- 3.6 TREATMENT OF METASTATIC BREAST CANCER 56 -- 3.6.1 Multidisciplinary approach 56 -- 3.6.2 Diagnosis of metastatic breast cancer 57 -- 3.6.3 Systemic treatment 57 -- 3.6.4 Treatment of bone metastases 62 -- 3.6.5 Treatment of brain metastases 62 -- 3.7 TREATMENT OF LOCOREGIONAL RELAPSE 63 -- 3.8 SUPPORTIVE CARE FOR PATIENTS WITH BREAST CANCER 63 -- 3.9 SURVEILLANCE OF PATIENTS WITH BREAST CANCER 64 -- 3.10 MULTIDISCIPLINARY APPROACH OF PATIENTS WITH BREAST CANCER 65 -- 3.11 BREAST CANCER AND PREGNANCY. 65 -- 3.12 PARTICIPATION IN CLINICAL TRIALS 66 -- 4 IMPLEMENTATION AND UPDATING OF THE BREAST CANCER GUIDELINE 66 -- 4.1 IMPLEMENTATION 66 -- 4.2 MONITORING THE QUALITY OF CARE 66 -- 4.3 GUIDELINE UPDATE 67 -- REFERENCES 68 |
| Link for e-copy: |
https://kce.fgov.be/sites/default/files/page_documents/KCE_143_Breast_cancer.pdf |
| Format of e-copy: |
PDF (1,03 Mb) |
| Record link: |
https://kce.docressources.info/index.php?lvl=notice_display&id=3228 |
|  |
Add the result to your basket Make a suggestion Refine your search Apply to external sourcesAnkle sprains / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
